Search
Biohaven Ltd
BHVNAdd to Watchlist
13.500USD
-0.330-2.39%
Close 07-31 16:00（ET）Quotes delayed by 15 min
2.03BMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated:Analyst Rating
Based on
17
analysts
Buy
Current Rating
23.571
Target Price
+74.60%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
496
Total
6
Median
7
Average
Company name
Ratings
Analysts
Biohaven Ltd
BHVN
17
Beigene Ltd
ONC
28
Ionis Pharmaceuticals Inc
IONS
27
argenx SE
ARGX
26
Kymera Therapeutics Inc
KYMR
24
Insmed Inc
INSM
23
1
2
3
...
99
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Biohaven Ltd's expected revenue for the next quarter?
Biohaven Ltd's expected revenue is 394.17K.
What is Biohaven Ltd's price target?
Analysts forecast that Biohaven Ltd's price target is USD 49.50, with the highest forecast at USD 75.00 and the lowest forecast at USD 19.00.
How have Biohaven LtdBHVN's recent earnings per share performed?
The market expectation was USD -0.88, while Biohaven LtdBHVN's earnings per share (EPS) for the previous quarter was USD -1.21. EPS for the next quarter is expected at USD -0.73.
What is the analyst rating for Biohaven Ltd?
Based on the ratings of Biohaven Ltd's stock from 17 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.